Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-02

Clinical Trial Update: Characterizing Protein Biomarkers of Post-infection Irritable Bowel Syndrome

View source ↗

Summary

A completed clinical trial characterizing protein biomarkers associated with post-infectious irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nevada, Reno | Conditions: Post-infectious Irritable Bowel Syndrome, Irritable Bowel Syndrome | Status: COMPLETED